| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
1 Etiology Program, Cancer Research Center of Hawaii, University of Hawaii, Honolulu, Hawaii and 2 Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California
Request for reprints:Loïc Le Marchand, Etiology Program, Cancer Research Center of Hawaii, University of Hawaii, 1236 Lauhala Street, Suite 407, Honolulu, HI 96813. Phone: 808-586-2988; Fax: 1-808-586-2982. E-mail: loic{at}crch.hawaii.edu
Methylenetetrahydrofolate reductase (MTHFR) is a key regulatory enzyme in the metabolism of folate, a nutrient which has recently been found to be inversely related to breast cancer in women who drink alcohol. Two common variants in the MTHFR gene (C677T and A1298C) have been associated with a reduced activity of this enzyme, thereby increasing the availability of folate for thymidylate and purine synthesis. We investigated the relationship of these variants with invasive breast cancer in a case-control study of 1,189 cases and 2,414 controls nested within the Multiethnic Cohort Study. The Multiethnic Cohort Study is a large prospective study of men and predominantly postmenopausal women of Japanese, White, African American, Latino, and Native Hawaiian origin, residing in Hawaii and Los Angeles. We found an overall nonsignificant, weak inverse association between breast cancer risk and the 677TT genotype and no association with the 1298C variant. The odds ratio [OR and 95% confidence interval (95% CI)] for the 677CC, 677CT, and 677TT genotypes were 1.00, 0.98 (0.83-1.15), and 0.86 (0.67-1.09), respectively. Those for the 1298AA, 1298AC, and 1298CC genotypes were 1.00, 0.93 (0.79-1.08), and 1.20 (0.88-1.65), respectively. However, the inverse association with the 677TT genotype was stronger (OR, 0.62; 95% CI 0.39-0.98) among women who were on hormone replacement therapy (HRT) at baseline, and the increased breast cancer risk due to HRT was not observed in women with the 677TT genotype. An increased breast cancer risk was suggested for alcohol intake >10 g/d, when compared with nondrinkers, but only among HRT users with the 677CC genotype (OR, 1.51; 95% CI, 0.96-2.37). Folate intake exhibited no modifying effect on the genotype-breast cancer relationship. These findings suggest that the MTHFR 677TT genotype may confer a 40% decreased breast cancer risk in postmenopausal women using HRT. This is consistent with the role of MTHFR in facilitating the flow of folate for thymidylate and purine synthesis and with the increased nucleic acid need resulting from the hyperproliferative effect of HRT on mammary epithelial cells.
This article has been cited by other articles:
|
|
 |
|
  U. Ericson, E. Sonestedt, M. I.L. Ivarsson, B. Gullberg, J. Carlson, H. Olsson, and E. Wirfalt Folate Intake, Methylenetetrahydrofolate Reductase Polymorphisms, and Breast Cancer Risk in Women from the Malmo Diet and Cancer Cohort Cancer Epidemiol. Biomarkers Prev., April 1, 2009; 18(4): 1101 - 1110. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Inoue, K. Robien, R. Wang, D. J. Van Den Berg, W.-P. Koh, and M. C. Yu Green tea intake, MTHFR/TYMS genotype and breast cancer risk: the Singapore Chinese Health Study Carcinogenesis, October 1, 2008; 29(10): 1967 - 1972. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M.-Y. Huang, Y.-H. Wang, F.-M. Chen, S.-C. Lee, W.-Y. Fang, T.-L. Cheng, M.-F. Hou, J.-Y. Wang, and S.-R. Lin Multiple Genetic Polymorphisms of GSTP1 313AG, MDR1 3435CC, and MTHFR 677CC Highly Correlated with Early Relapse of Breast Cancer Patients in Taiwan Ann. Surg. Oncol., March 1, 2008; 15(3): 872 - 880. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Suzuki, K. Matsuo, K. Hirose, A. Hiraki, T. Kawase, M. Watanabe, T. Yamashita, H. Iwata, and K. Tajima One-carbon metabolism-related gene polymorphisms and risk of breast cancer Carcinogenesis, February 1, 2008; 29(2): 356 - 362. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Xu, M. D. Gammon, H. Zhang, J. G. Wetmur, M. Rao, S. L. Teitelbaum, J. A. Britton, A. I. Neugut, R. M. Santella, and J. Chen Polymorphisms of one-carbon-metabolizing genes and risk of breast cancer in a population-based study Carcinogenesis, July 1, 2007; 28(7): 1504 - 1509. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. L. Stevens, M. L. McCullough, A. L. Pavluck, J. T. Talbot, H. S. Feigelson, M. J. Thun, and E. E. Calle Association of Polymorphisms in One-Carbon Metabolism Genes and Postmenopausal Breast Cancer Incidence Cancer Epidemiol. Biomarkers Prev., June 1, 2007; 16(6): 1140 - 1147. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. C. Larsson, E. Giovannucci, and A. Wolk Folate and Risk of Breast Cancer: A Meta-analysis J Natl Cancer Inst, January 3, 2007; 99(1): 64 - 76. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. F. Zhang, M. B. Terry, L. Hou, J. Chen, J. Lissowska, M. Yeager, W. Zatonski, S. Chanock, A. Morabia, and W.-H. Chow Genetic Polymorphisms in Folate Metabolism and the Risk of Stomach Cancer Cancer Epidemiol. Biomarkers Prev., January 1, 2007; 16(1): 115 - 121. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. J. Lewis, R. M. Harbord, R. Harris, and G. D. Smith Meta-analyses of Observational and Genetic Association Studies of Folate Intakes or Levels and Breast Cancer Risk. J Natl Cancer Inst, November 15, 2006; 98(22): 1607 - 1622. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. N. Martin, J. E. Olson, J. N. Ingle, R. A. Vierkant, Z. S. Fredericksen, V. S. Pankratz, Y. Wu, D. J. Schaid, T. A. Sellers, and R. M. Weinshilboum Methylenetetrahydrofolate Reductase Haplotype Tag Single-Nucleotide Polymorphisms and Risk of Breast Cancer. Cancer Epidemiol. Biomarkers Prev., November 1, 2006; 15(11): 2322 - 2324. [Full Text] [PDF]
|
|
|
|
|
|
Y.-C. Chou, M.-H. Wu, J.-C. Yu, M.-S. Lee, T. Yang, H.-L. Shih, T.-Y. Wu, and C.-A. Sun Genetic polymorphisms of the methylenetetrahydrofolate reductase gene, plasma folate levels and breast cancer susceptibility: a case-control study in Taiwan Carcinogenesis, November 1, 2006; 27(11): 2295 - 2300. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Rodenhiser and M. Mann Epigenetics and human disease: translating basic biology into clinical applications Can. Med. Assoc. J., January 31, 2006; 174(3): 341 - 348. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Justenhoven, U. Hamann, C. B. Pierl, S. Rabstein, B. Pesch, V. Harth, C. Baisch, C. Vollmert, T. Illig, T. Bruning, et al. One-Carbon Metabolism and Breast Cancer Risk: No Association of MTHFR, MTR, and TYMS Polymorphisms in the GENICA Study from Germany Cancer Epidemiol. Biomarkers Prev., December 1, 2005; 14(12): 3015 - 3018. [Full Text] [PDF]
|
|
|
|
|
|
L. Le Marchand, T. Donlon, L. N. Kolonel, B. E. Henderson, and L. R. Wilkens Estrogen Metabolism-Related Genes and Breast Cancer Risk: The Multiethnic Cohort Study Cancer Epidemiol. Biomarkers Prev., August 1, 2005; 14(8): 1998 - 2003. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Le Marchand, L. R. Wilkens, L. N. Kolonel, and B. E. Henderson The MTHFR C677T Polymorphism and Colorectal Cancer: The Multiethnic Cohort Study Cancer Epidemiol. Biomarkers Prev., May 1, 2005; 14(5): 1198 - 1203. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
